Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
journalStr:"Alimentary pharmacology & therapeutics"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Adalimumab%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22Alimentary+pharmacology+%26+therapeutics%22
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Adalimumab%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22Alimentary+pharmacology+%26+therapeutics%22
Search /vufind/Search2/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Adalimumab%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22Alimentary+pharmacology+%26+therapeutics%22
PubPharm (157)
1
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease : The ADA-SWITCH study
enthalten in:
Alimentary pharmacology & therapeutics
| 2023
von
Casanova, M.
|
Nantes, .
|
Varela, P.
| +39
Wird geladen...
2
The inexorable increase of biologic exposure in paediatric inflammatory bowel disease : a Scottish, population-based, longitudinal study
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Burgess, C.
|
Jackson, R.
|
Chalmers, I.
| +5
CommentIn: Aliment Pharmacol Ther. 2022 Dec;56(11-12):1619-1620. - PMID 36352749
Wird geladen...
3
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease : results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Chanchlani, N.
|
Lin, S.
|
Auth, M.
| +99
CommentIn: Aliment Pharmacol Ther. 2022 Oct;56(8):1294-1295. - PMID 36168263
Wird geladen...
4
Meta-analysis : hepatitis B reactivation in patients receiving biological therapy
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
El Jamaly, H.
|
Eslick, G.
|
Weltman, M.
Wird geladen...
5
Understanding anti-TNF treatment failure : does serum triiodothyronine-to-thyroxine (T3/T4) ratio predict therapeutic outcome to anti-TNF therapies in biologic-naïve patients with active luminal Crohn's disease?
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Lin, S.
|
Chanchlani, N.
|
Carbery, I.
| +9
CommentIn: Aliment Pharmacol Ther. 2022 Sep;56(5):903-904. - PMID 35934852
Wird geladen...
6
Editorial : choosing the optimal screening method for latent TB in patients with IBD commencing anti-TNF therapy
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Lovatt, J.
|
Selinger, C.
CommentOn: Aliment Pharmacol Ther. 2022 Jun;55(11):1431-1440. - PMID 35229906
Wird geladen...
7
Editorial : choosing the optimal screening method for latent TB in patients with IBD commencing anti-TNF-therapy-authors' reply
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Kumar, P.
|
Vuyyuru, S.
|
Kedia, S.
| +1
CommentOn: Aliment Pharmacol Ther. 2022 Jun;55(11):1431-1440. - PMID 35229906
Wird geladen...
8
Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease
enthalten in:
Alimentary pharmacology & therapeutics
| 2021
von
Schultheiss, J.
|
Mahmoud, R.
|
Louwers, J.
| +7
CommentIn: Aliment Pharmacol Ther. 2022 Jan;55(2):246. - PMID 34970765
Wird geladen...
9
Higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease
enthalten in:
Alimentary pharmacology & therapeutics
| 2021
von
Takenaka, K.
|
Kawamoto, A.
|
Hibiya, S.
| +9
CommentIn: Aliment Pharmacol Ther. 2021 Oct;54(8):1085-1086. - PMID 34564884
Wird geladen...
10
Limited long-term treatment persistence of first anti-TNF therapy in 538 patients with inflammatory bowel diseases : a 20-year real-world study
enthalten in:
Alimentary pharmacology & therapeutics
| 2021
von
Blesl, A.
|
Binder, L.
|
Högenauer, C.
| +8
CommentIn: Aliment Pharmacol Ther. 2021 Sep;54(5):720-721. - PMID 34379834
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Alimentary pharmacology & therapeutics
Medienart
157
Aufsätze
153
E-Artikel
153
E-Ressourcen
4
Gedruckte Aufsätze
Zeitschriftentitel
Alimentary pharmacology & therapeutics
Thema
156
Adalimumab
156
FYS6T7F842
125
B72HH48FLU
125
Infliximab
121
Journal Article
82
Antibodies, Monoclonal, Humanized
76
Tumor Necrosis Factor-alpha
75
Antibodies, Monoclonal
61
Research Support, Non-U.S. Gov't
57
Anti-Inflammatory Agents
36
Comment
23
Gastrointestinal Agents
22
Review
20
Immunologic Factors
18
Editorial
18
Letter
15
Certolizumab Pegol
15
Systematic Review
15
UMD07X179E
14
9RV78Q2002
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
27
2020-
108
2010-2019
22
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
157
Englisch
Haven't found what you're looking for?
Wird geladen...